Scholarly Index
Kala Visvanathan
Mayo Clinic; 21,834 total citations; 503 total publications; best world rank #27
Mayo Clinic
21,834Total citations
503Total publications
74H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Cancer Risks and Factors | Lifetime | 320 | US 165 | 97.80 |
| Ovarian cancer diagnosis and treatment | Lifetime | 800 | US 359 | 97.03 |
| Cancer, Stress, Anesthesia, and Immune Response | Lifetime | 297 | US 147 | 94.04 |
| BRCA gene mutations in cancer | Lifetime | 682 | US 355 | 95.94 |
| Multiple and Secondary Primary Cancers | Lifetime | 632 | US 273 | 94.20 |
| Inflammatory Biomarkers in Disease Prognosis | Lifetime | 774 | US 119 | 89.93 |
| Cancer Risks and Factors | 2021-2025 | 27 | US 15 | 97.64 |
| Multiple and Secondary Primary Cancers | 2021-2025 | 127 | US 56 | 89.36 |
| BRCA gene mutations in cancer | 2021-2025 | 301 | US 147 | 91.81 |
| Global Cancer Incidence and Screening | 2021-2025 | 583 | US 246 | 91.64 |
| Cancer Diagnosis and Treatment | 2021-2025 | 597 | US 138 | 79.27 |
| Nutrition, Genetics, and Disease | 2021-2025 | 618 | US 154 | 73.89 |
| Chemotherapy-induced cardiotoxicity and mitigation | 2021-2025 | 966 | US 252 | 67.77 |